Amedisys Inc
(AMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 38,162 | -10,936 | 117,699 | 210,166 | 185,184 |
| Depreciation Amortization | 61,452 | 58,834 | 71,955 | 72,182 | 68,811 |
| Income taxes - deferred | 7,416 | 20,655 | 23,377 | 44,582 | -26,560 |
| Accounts receivable | 16,477 | -26,727 | -14,230 | -18,030 | 2,114 |
| Accounts payable and accrued liabilities | 12,210 | -15,816 | 4,894 | -4,353 | 1,941 |
| Other Working Capital | 39,895 | -63,207 | -105,044 | -131,018 | 26,222 |
| Other Operating Activity | 46,053 | 174,385 | 34,632 | 15,364 | 31,240 |
| Operating Cash Flow | $221,665 | $137,188 | $133,283 | $188,893 | $288,952 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,869 | -6,943 | -16,687 | -5,619 | -875 |
| PPE Investments | -6,550 | -5,484 | -6,099 | -6,158 | -5,252 |
| Net Acquisitions | N/A | 47,437 | -71,952 | -269,965 | -298,958 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 17,876 |
| Other Investing Activity | 55 | 54 | 252 | 135 | 101 |
| Investing Cash Flow | $-8,364 | $35,064 | $-94,486 | $-281,607 | $-287,108 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 500,700 | 684,200 |
| Debt Issued | N/A | 23,000 | 534,500 | 290,312 | N/A |
| Debt Repayment | -37,357 | -99,013 | -547,796 | -9,143 | -10,249 |
| Common Stock Issued | 309 | 2,702 | 6,152 | 6,022 | 9,887 |
| Common Stock Repurchased | -6,152 | -7,329 | -25,332 | -116,776 | -54,493 |
| Dividend Paid | -1,150 | -421 | 1,940 | -1,497 | -1,122 |
| Other Financing Activity | -4,572 | -6,461 | 103 | -614,492 | -643,200 |
| Financing Cash Flow | $-48,922 | $-87,522 | $-30,433 | $55,126 | $-14,977 |
| Beginning Cash Position | 138,863 | 54,133 | 45,769 | 83,357 | 96,490 |
| End Cash Position | 303,242 | 138,863 | 54,133 | 45,769 | 83,357 |
| Net Cash Flow | $164,379 | $84,730 | $8,364 | $-37,588 | $-13,133 |
| Free Cash Flow | |||||
| Operating Cash Flow | 221,665 | 137,188 | 133,283 | 188,893 | 288,952 |
| Capital Expenditure | -6,550 | -5,620 | -6,165 | -6,302 | -5,332 |
| Free Cash Flow | 215,115 | 131,568 | 127,118 | 182,591 | 283,620 |